Benzinga · Mar 5, 2026
Canaccord Genuity Maintains Hold on Quantum-Si, Lowers Price Target to $1
Canaccord Genuity analyst Kyle Mikson maintains Quantum-Si (NASDAQ:QSI) with a Hold and lowers the price target from $1.5 to $1.
QS
NASDAQ · QSI
Quantum-Si incorporated
Healthcare · Biotechnology
$1.28
Down-$0.04 (-2.73%)
Updated Oct 6, 2026, 5:33 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 272.8M
- P/E ratio
- -2.41
- Dividend yield
- 0.00%
- 52-week range
- $0.69 – $1.55
- Volume
- 19.18M
- Avg. volume
- 11.82M
Price performance · QSI
QSI price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
QSI closed at $1.28 after 20 trading sessions, up 68.42% for the selected period.
- Last close
- $1.28
- Period change
- +68.42%
- Period low
- $0.72
- Period high
- $1.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $1.525 | $1.53 | $1.2601 | $1.28 | 19.18M |
| Oct 2, 2026 | $1.385 | $1.55 | $1.17 | $1.55 | 18.77M |
| Oct 1, 2026 | $1.20 | $1.48 | $1.15 | $1.43 | 33.06M |
| Sep 30, 2026 | $0.96 | $1.12 | $0.96 | $1.07 | 13.84M |
| Sep 29, 2026 | $0.805 | $1.03 | $0.805 | $0.9581 | 23.01M |
| Sep 28, 2026 | $0.825 | $0.8338 | $0.795 | $0.795 | 1.57M |
| Sep 25, 2026 | $0.7943 | $0.84 | $0.7755 | $0.8343 | 2.59M |
| Sep 24, 2026 | $0.75 | $0.7991 | $0.7434 | $0.785 | 1.59M |
| Sep 23, 2026 | $0.79 | $0.805 | $0.7515 | $0.7587 | 1.48M |
| Sep 22, 2026 | $0.76 | $0.792 | $0.7511 | $0.7847 | 2.43M |
| Sep 21, 2026 | $0.7588 | $0.7661 | $0.75 | $0.7559 | 1.13M |
| Sep 18, 2026 | $0.79 | $0.8015 | $0.74 | $0.7451 | 1.71M |
| Sep 17, 2026 | $0.7495 | $0.7963 | $0.7495 | $0.77 | 2.83M |
| Sep 16, 2026 | $0.721 | $0.7532 | $0.721 | $0.7301 | 915.22K |
| Sep 15, 2026 | $0.72 | $0.7409 | $0.72 | $0.72 | 1.17M |
| Sep 14, 2026 | $0.7287 | $0.7478 | $0.7201 | $0.725 | 1.39M |
| Sep 11, 2026 | $0.7391 | $0.755 | $0.7391 | $0.74 | 1.07M |
| Sep 10, 2026 | $0.75 | $0.755 | $0.7251 | $0.7391 | 1.72M |
| Sep 9, 2026 | $0.7602 | $0.7748 | $0.746 | $0.75 | 1.45M |
| Sep 8, 2026 | $0.7672 | $0.79 | $0.76 | $0.76 | 1.05M |
Latest QSI news
The latest Smart Investors Daily articles mentioning QSI.
Stock researchCompany · Overview
Company
Market Activity
Research & News
QSI research
Overview
Company profile and research snapshot.
Company profile
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $2.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 29, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 5, 2026 | Canaccord Genuity | Hold | — |
| Dec 22, 2025 | Canaccord Genuity | Hold | — |
| Oct 27, 2025 | Canaccord Genuity | Hold | — |
| Sep 9, 2025 | Canaccord Genuity | Hold | — |
News briefing
No generated briefing is available yet.
ChartMill · Mar 3, 2026
Quantum-Si (NASDAQ:QSI) Reports Q4 2025 Revenue Miss, Guides for Strategic Transition Year
Quantum-Si reports Q4 revenue miss, lowers 2026 outlook to focus on launching its next-generation Proteus protein analysis platform.
Benzinga · Mar 3, 2026
Quantum-Si Shares Slip After Q4 Revenue Miss
Here's a look at why Quantum-Si stock is slipping after Q4 earnings.
Benzinga · Mar 3, 2026
Quantum-Si Sees FY2026 Sales $1.000M vs $7.148M Est
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
